Richard Aspinall
Overview
Explore the profile of Richard Aspinall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crisp H, Tavabie O, Enever Y, Allen R, Silverman M, Acevedo J, et al.
NIHR Open Res
. 2025 Feb;
4:69.
PMID: 39931700
Liver disease is a major, and increasing, cause of death in the UK. The UK Chronic Liver Failure network (UK-CLIF) was developed as a multi-stakeholder network with the aim to...
2.
Govind S, Lang P, Burkle A, Moreno-Villanueva M, Franceschi C, Capri M, et al.
Immun Ageing
. 2024 Nov;
21(1):84.
PMID: 39609853
Decline in immune function with age has been studied extensively, but approaches to immune restoration have been hampered by the lack of simple methods of identifying individuals whose immune system...
3.
Parker R, Allison M, Anderson S, Aspinall R, Bardell S, Bains V, et al.
BMJ Open Gastroenterol
. 2023 Oct;
10(1).
PMID: 37797967
Objective: Alcohol-related liver disease (ALD) is the most common cause of liver-related ill health and liver-related deaths in the UK, and deaths from ALD have doubled in the last decade....
4.
Abbas N, Culver E, Thorburn D, Halliday N, Crothers H, Dyson J, et al.
Clin Gastroenterol Hepatol
. 2022 Aug;
21(6):1561-1570.e13.
PMID: 35961518
Background & Aims: Thirty-to-forty percent of patients with primary biliary cholangitis inadequately respond to ursodeoxycholic acid. Our aim was to assemble national, real-world data on the effectiveness of obeticholic acid...
5.
Meyfroidt P, de Bremond A, Ryan C, Archer E, Aspinall R, Chhabra A, et al.
Proc Natl Acad Sci U S A
. 2022 Feb;
119(7).
PMID: 35131937
Land use is central to addressing sustainability issues, including biodiversity conservation, climate change, food security, poverty alleviation, and sustainable energy. In this paper, we synthesize knowledge accumulated in land system...
6.
Williams R, Alessi C, Alexander G, Allison M, Aspinall R, Batterham R, et al.
Lancet
. 2021 Mar;
397(10286):1770-1780.
PMID: 33714360
This Review, in addressing the unacceptably high mortality of patients with liver disease admitted to acute hospitals, reinforces the need for integrated clinical services. The masterplan described is based on...
7.
Scorletti E, Afolabi P, Miles E, Smith D, Almehmadi A, Alshathry A, et al.
Gastroenterology
. 2020 Jan;
158(6):1597-1610.e7.
PMID: 31987796
Background & Aims: Dysbiosis of the intestinal microbiota has been associated with nonalcoholic fatty liver disease (NAFLD). We investigated whether administration of a synbiotic combination of probiotic and prebiotic agents...
8.
Williams R, Aithal G, Alexander G, Allison M, Armstrong I, Aspinall R, et al.
Lancet
. 2019 Dec;
395(10219):226-239.
PMID: 31791690
This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity, with high...
9.
Lang P, Aspinall R
Aging Clin Exp Res
. 2019 Oct;
33(4):1113-1122.
PMID: 31643072
Current vaccination policy in most high-income countries aims to counteract the decline in cell-mediated immunity to varicella zoster virus that occurs with advancing age or immunosuppression. The aim of this...
10.
Lacoin L, Hurst M, Hill N, Gordon J, Geretti A, Aspinall R, et al.
BMJ Open
. 2019 Aug;
9(8):e029066.
PMID: 31383704
Objective: To evaluate the impact of treatment with new direct-acting antivirals (DAAs) on the prevalent hepatitis C virus (HCV) population in England. Design: A repeated cross-sectional analysis. Setting: Four secondary...